Meet RxStrategies in Philadelphia for 340B Summit

Jonathan Ghenn and Rhodie Smith will be attending and meeting with industry leaders during the 4th Annual Covered Entities 340B Summit hosted by World Congress, May 16 – 17 in Philadelphia, PA. RxStrategies is proud to be a Supporting Sponsor for the Summit. This event brings HRSA grantees and covered entities together to discuss the… Read more »

Ryen Brumbeloe and Todd Hudnall will attend and exhibit at the Comprehensive Pharmacy Systems/Pharmacy Systems, Inc. (CPS) Annual Meeting & Vendor Expo in Indianapolis, IN. There, over hundreds of pharmacy decision makers will connect and gain insight into the latest industry news. Visit us on May 16 to network with our team members. Contact us… Read more »

Justin Rolling, Krista Scanlon and Rhodie Smith are attending the Health Connect Partners (HCP) 2019 Spring Hospital Pharmacy Conference, May 6 – 8 in Miami. During the event, America’s most prestigious hospitals and health systems will come together to gain industry-leading insight and education and network through the two Reverse EXPO sessions. Be sure to connect… Read more »

Did you know? Mixed-use inventory virtualization and replenishment platforms through RxStrategies are secure, user-friendly, highly customizable and work with all wholesalers and EHRs. In fact, RxStrategies’ integration of the Medi-Span drug database minimizes the need for manual NDC and multiplier mapping, while system-logic seamlessly complies with state-level MCO reporting requirements. Real-time drug cost analytics… Read more »

March 27 – 30, RxStrategies representatives Rhodie Smith and Justin Rolling will attend the 2019 Policy and Issues Forum hosted by the National Association of Community Health Centers (NACHC). As one of the largest conferences on health policy, people from all corners of the administration and operations of health care will attend. The priorities… Read more »

It was great to connect with industry leaders during the 15th Annual 340B Coalition Winter Conference! As a pharmacist, clinic director, or C-suite executive, one of your top priorities is to provide safe and cost-effective care and ensure regulatory compliance. RxStrategies understands the complexities of the 340B program and recognizes the importance of open communication… Read more »

Welcome to RxStrategies Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval Tosymra™ (sumatriptan) – New Drug Approval – January 28, 2019 – Dr. Reddy’s Laboratories Ltd. and its subsidiary, Promius Pharma, LLC announced the approval of… Read more »

Welcome to the December 27, 2018 edition of RxStrategies Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. New Drug Approval Ultomiris™ (ravulizumab)– New Drug Approval – December 21, 2018 – The U.S. Food and Drug Administration approved Ultomiris™ (ravulizumab) injection for the treatment of adult patients with paroxysmal… Read more »

Categories

Archives

Archives

What clients say about RxStrategies:

"Due to RxStrategies' comprehensive solutions specifically for FQHCs to manage a compliant 340B program, our available discounts from the 340B program tripled in the rural areas where we operate in partnership with contract pharmacies."

"Communication throughout the transition process from another TPA was stellar. The RxStrategies team was there for us at a moment’s notice."

"The exemplary customer service RxStrategies' sales department and account managers provide is a key component of our strong partnership."